Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 16, 2016 - Issue 2
Submit an article Journal homepage
4,798
Views
29
CrossRef citations to date
0
Altmetric
Drug Profiles

Overcoming crizotinib resistance in ALK-rearranged NSCLC with the second-generation ALK-inhibitor ceritinib

Ittai B MullerDepartment of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands
,
Adrianus J De LangenDepartment of Medical Pulmonology, VU University Medical Center, Amsterdam, The Netherlands
,
Richard J HoneywellDepartment of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands
,
Elisa GiovannettiDepartment of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands;Cancer Pharmacology Lab, AIRC Start-Up Unit, DIPINT, Pisa, Italy
&
Godefridus J PetersDepartment of Medical Oncology, VU University Medical Center, Amsterdam, The NetherlandsCorrespondence[email protected]
Pages 147-157 | Received 30 Jul 2015, Accepted 10 Dec 2015, Published online: 04 Jan 2016

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.